Dutasteride and Tadalafil Tablet 0.5/5 mg

Dutasteride and Tadalafil Tablet 0.5/5 mg
Product Description

We have developed novel combination of marketed individual Dutasteride and Tadalafil (Avodart + Cialis) for BPH indication. The combination of tadalafil with dutasteride provide better therapeutic effect in improvement of BPH and LUTs symptoms while reduce adverse effect profile particularly Erectile dysfunction (ED) and decreased libido. Our novel combination tablet is just 8mm in size which reduce concerns around dysphagia (swallowing problem) and polypharmacy, eventually driving compliance

The product development is completed and Bio-equivalency established between our product and RLD’s (Avodart + Cialis). We are in-process of filing formulation patent.

Global market for Dutasteride & Tadalafil in BPH is ~955M USD. Our plan is to launch this product globally. We are seeking partner for registration and global launch. 

Read more Show less

YUYU PHARMA

  • KR
  • 2023
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
OTC
Pharmaceutical Company (generic finished products)
View company profile
Categories
more categories Show less
Specifications
  • Selling Points
    Brand Name; Product Performance; Novel Therapy for better therapeutic effect in BPH and LUTs while reduce adverse effect profile. Novel combination reduce polypharmacy concern and small pill size to reduce swallowing problem in elder patient eventually driving compliance.
  • Model
    Novel Therapy in Urology
  • Supplied from
    India; Korea, Republic Of
More specifications Fewer specifications
Sales Markets
Show more Show less

YUYU PHARMA

  • KR
  • 2023
    On CPHI since
  • 2
    Certificates
  • 250 - 499
    Employees
Company types
Distributor/Import Export
Generics/Biosimilars Manufacturer
OTC
Pharmaceutical company
Primary activities
Contract Manufacturer
Finished Formulation products Distributor/Buyer
OTC
Pharmaceutical Company (generic finished products)
View company profile

More Products from YUYU PHARMA (3)

  • Calcitriol 1μg

    Product Calcitriol 1μg

    1. Efficacy & Effectiveness

    1) Treatment for hypocalcemia in chronic kidney dialysis patients.

    2) Improvement of skeletal dysplasia by remarkable reducing elevated parathyroid hormone levels.

    2. Administration & Dosage

    The initial recommend...
  • Dutasteride and Tamsulosin HCl Capsules 0.5/0.4 mg

    Product Dutasteride and Tamsulosin HCl Capsules 0.5/0.4 mg

    We have developed novel small capsules of marketed Dutasteride and Tamsulosin HCl Capsules (Jalyn/Duodart/Combodart)) for BPH indication. The marketed product is a big pill, 23mm in length above FDA’s recommendation (22mm). Large pill size of marketed product considered burdensome for patients; potenti...
  • Dutasteride Tablet 0.5 mg

    Product Dutasteride Tablet 0.5 mg

    We have developed novel small tablet of marketed Dutasteride Softgel (Avodart) for BPH and acute urinary retention indication. This small pill will help to resolve swallowing difficulties in elder population where BPH in more prevalent (80% Male at 80 Yr old).

    The product development...